Medtronic
Medtronic plc, a global leader in medical technology, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1949, the company has pioneered advancements in various medical fields, including cardiovascular, diabetes, and neurological care. Medtronic is renowned for its innovative core products, such as insulin pumps, cardiac devices, and surgical instruments, which are designed to improve patient outcomes and enhance quality of life. The company’s commitment to research and development has positioned it as a market leader, with notable achievements including the first successful implant of a cardiac pacemaker. With a strong focus on patient-centric solutions, Medtronic continues to set industry standards, making significant contributions to healthcare worldwide.
DitchCarbon Score
How does Medtronic's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medtronic's score of 40 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medtronic's reported carbon emissions
In 2023, Medtronic reported total carbon emissions of approximately 622,000,000 kg CO2e, comprising 256,800,000 kg CO2e from Scope 1, 122,400,000 kg CO2e from Scope 2, and 242,800,000 kg CO2e from Scope 3 emissions. This reflects the company's ongoing commitment to sustainability and climate action. Medtronic has set ambitious long-term targets to achieve net-zero emissions across all scopes by 2050, with interim commitments established through the Science Based Targets initiative (SBTi). The company is actively working towards reducing its carbon footprint, with a focus on improving emissions intensity per unit of revenue, which was reported at approximately 8,200 kg CO2e per million USD in 2023. The company has demonstrated a commitment to transparency in its emissions reporting and has disclosed its emissions data across all relevant scopes. Medtronic's initiatives align with industry standards for climate action, reflecting its dedication to reducing environmental impact while continuing to provide essential healthcare solutions.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 74,992,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 269,008,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 299,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medtronic is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
